TP53 and neoplasm: While ESWR1 is typically a constituent of an oncogenic fusion protein, and the R45W mutation in the ATM serine/threonine kinase tumor suppressor is not yet characterized, the Y220C mutation is a known TP53 hotspot that decreases protein stability23,24.